,Receptor,PDBID,Receptor_chain,Resolution,DOI,PMID,Title,Authors,AUC_FoldX,AUC_RosettaTalarisInterfacedGcross,AUC_RosettaTalarisInterfacedGseparated,AUC_RosettaTalarisPose,AUC_RosettabetaInterfacedGcross,AUC_RosettabetaInterfacedGseparated,AUC_RosettabetaPose,AUC_dTERMenC34,AUC_dTERMenC35,Cor_FoldX,Cor_RosettaTalarisInterfacedGcross,Cor_RosettaTalarisInterfacedGseparated,Cor_RosettaTalarisPose,Cor_RosettabetaInterfacedGcross,Cor_RosettabetaInterfacedGseparated,Cor_RosettabetaPose,Cor_dTERMenC34,Cor_dTERMenC35,Enrich_FoldX,Enrich_RosettaTalarisInterfacedGcross,Enrich_RosettaTalarisInterfacedGseparated,Enrich_RosettaTalarisPose,Enrich_RosettabetaInterfacedGcross,Enrich_RosettabetaInterfacedGseparated,Enrich_RosettabetaPose,Enrich_dTERMenC34,Enrich_dTERMenC35
B2CL1_HUMAN_1G5J_A,B2CL1,1G5J,A,-999.0,10.1017/S096183680000331X,11206074,"RATIONALE FOR BCL-XL/BAD PEPTIDE COMPLEX FORMATION FROMSTRUCTURE, MUTAGENESIS, AND BIOPHYSICAL STUDIES.","A.M.PETROS,D.G.NETTESHEIM,Y.WANG,E.T.OLEJNICZAK,R.P.MEADOWS,J.MACK,K.SWIFT,E.D.MATAYOSHI,H.ZHANG,C.B.THOMPSON,S.W.FESIK",0.7834291375791583,0.5618879067495194,0.5620420001552348,0.6008427197143679,0.6543835513130202,0.6545640901414373,0.5798061607161221,0.7352161645124028,0.8366141912036635,0.3097674699970942,0.11133426624113094,0.1107297954462658,0.13727805278111282,0.18591113678451535,0.1861411605676966,0.11119320133214423,0.2841564424626169,0.41603663482914605,23.02781577747378,16.187870497036023,15.503875968992247,15.959872321021432,16.678090015992687,16.678090015992687,14.164953164267763,17.55585955312357,28.727770177838575
B2CL1_HUMAN_2M04_A,B2CL1,2M04,A,-999.0,10.1038/NCHEMBIO.1166,23340338,PUMA BINDING INDUCES PARTIAL UNFOLDING WITHIN BCL-XL TODISRUPT P53 BINDING AND PROMOTE APOPTOSIS.,"A.V.FOLLIS,J.E.CHIPUK,J.C.FISHER,M.K.YUN,C.R.GRACE,A.NOURSE,K.BARAN,L.OU,L.MIN,S.W.WHITE,D.R.GREEN,R.W.KRIWACKI",0.7048335106358694,0.6122804454326715,0.6225972843034749,0.527341306620766,0.6772956531079102,0.6772956531079102,0.5351046787194025,0.6659506079270213,0.7308467603858956,0.2082463865393219,0.1320119328951819,0.14535107775140965,0.03898202940295612,0.18181783063877377,0.18182151839341382,0.06399299293784975,0.22469095372845457,0.3339632129153447,13.907888736890103,13.451892384860919,15.047879616963064,10.487916096671226,13.467244921250856,13.467244921250856,11.41291942478886,31.69174646602827,27.587779297765618
B2CL1_HUMAN_2P1L_A,B2CL1,2P1L,A,2.5,10.1074/JBC.M700492200,17337444,CRYSTAL STRUCTURE OF THE BCL-XL-BECLIN 1 PEPTIDE COMPLEX:BECLIN 1 IS A NOVEL BH3-ONLY PROTEIN,"A.OBERSTEIN,P.D.JEFFREY,Y.SHI",0.6384546371842226,0.5467319642229355,0.5469665286294134,0.5187771375608954,0.6230096856383213,0.6230096856383213,0.5554100284355372,0.7373232491564812,0.7318820397857759,0.18848067659734796,0.13376911283759133,0.1359391471418008,0.09268099769255012,0.19281424204064102,0.19281424204064102,0.12550598558606887,0.3266701525214554,0.3437294040746871,13.679890560875513,15.503875968992247,14.59188326493388,13.679890560875513,17.64840705936282,17.64840705936282,13.293605317442125,32.375740994072046,30.779753761969904
B2CL1_HUMAN_2P1L_C,B2CL1,2P1L,C,2.5,10.1074/JBC.M700492200,17337444,CRYSTAL STRUCTURE OF THE BCL-XL-BECLIN 1 PEPTIDE COMPLEX:BECLIN 1 IS A NOVEL BH3-ONLY PROTEIN,"A.OBERSTEIN,P.D.JEFFREY,Y.SHI",0.7954033366358785,0.51570154732608,0.5317472365915908,0.6253150354072403,0.6248083997547517,0.6248083997547517,0.5957698097495356,0.8037512042114299,0.7715388338211054,0.2722131462563556,0.11348233093896688,0.13505062273602889,0.21984971903742367,0.18126676553315527,0.18126676553315527,0.15682448126227982,0.3885189902762651,0.37201223559648416,32.375740994072046,15.959872321021432,15.503875968992247,20.51983584131327,20.105094813799408,20.105094813799408,18.9584285061672,29.639762881896942,30.55175558595531
B2CL1_HUMAN_2P1L_E,B2CL1,2P1L,E,2.5,10.1074/JBC.M700492200,17337444,CRYSTAL STRUCTURE OF THE BCL-XL-BECLIN 1 PEPTIDE COMPLEX:BECLIN 1 IS A NOVEL BH3-ONLY PROTEIN,"A.OBERSTEIN,P.D.JEFFREY,Y.SHI",0.7574078978006875,0.5650976153189391,0.5710747273117436,0.6058815740812609,0.6245886098077944,0.6245886098077944,0.5743855369480264,0.7559137624815659,0.75760993137707,0.26140298485664626,0.16014155254500373,0.16865242414515766,0.16243524379461075,0.1911590447590335,0.1911590447590335,0.143717346787086,0.34636436883686467,0.3499138392433993,27.815777473780205,15.047879616963064,15.047879616963064,18.923848609211124,19.18684330744632,19.18684330744632,14.16171767930562,25.99179206566347,29.639762881896942
B2CL1_HUMAN_2P1L_G,B2CL1,2P1L,G,2.5,10.1074/JBC.M700492200,17337444,CRYSTAL STRUCTURE OF THE BCL-XL-BECLIN 1 PEPTIDE COMPLEX:BECLIN 1 IS A NOVEL BH3-ONLY PROTEIN,"A.OBERSTEIN,P.D.JEFFREY,Y.SHI",0.6529474073499131,0.5108624436702995,0.5168406970957388,0.579133812430658,0.7202730957430206,0.7202730957430206,0.6103256079759839,0.7409632778292692,0.7627874698091066,0.1833269705961095,0.10776739795558697,0.11737645166858143,0.16030943725030608,0.26395677023551783,0.26395677023551783,0.16604087934034262,0.33300265680708063,0.36542651839600093,17.783857729138166,10.259917920656635,12.083903328773369,18.695850433196533,23.308957952468006,23.308957952468006,16.224862888482633,33.05973552211582,33.97172822617419
B2CL1_HUMAN_2PON_B,B2CL1,2PON,B,-999.0,10.1016/J.JMB.2007.06.069,17659302,MOLECULAR BASIS OF BCL-XL'S TARGET RECOGNITIONVERSATILITY REVEALED BY THE STRUCTURE OF BCL-XL INCOMPLEX WITH THE BH3 DOMAIN OF BECLIN-1.,"W.FENG,S.HUANG,H.WU,M.ZHANG",0.3934044598055912,0.7104076969085438,0.7108796793030869,0.6711093127205818,0.7386145078814251,0.7386076225361939,0.5972669769662251,0.8000061637362286,0.7989720257689833,-0.06850228133768636,0.30132005465955375,0.30344061154534596,0.22405149246731773,0.2713008471949671,0.2713524151652223,0.12809668275508204,0.3818942348333749,0.39690074014787347,8.663930688554492,20.51983584131327,21.203830369357043,19.607843137254903,18.510054844606945,18.510054844606945,13.025594149908592,25.763793889648884,28.0437756497948
B2CL1_HUMAN_3FDL_A,B2CL1,3FDL,A,1.78,10.1002/ANIE.200805761,19229915,HIGH-RESOLUTION STRUCTURAL CHARACTERIZATION OF A HELICALALPHA/BETA-PEPTIDE FOLDAMER BOUND TO THE ANTI-APOPTOTICPROTEIN BCL-X(L),"E.F.LEE,J.D.SADOWSKY,B.J.SMITH,P.E.CZABOTAR,K.J.PETERSON-KAUFMAN,P.M.COLMAN,S.H.GELLMAN,W.D.FAIRLIE",0.7043706597024058,0.6138847290010638,0.6083984330412788,0.6320631851449391,0.7103027267463767,0.710669762248302,0.6614433513155838,0.7720307912867599,0.7178161654255488,0.30348908747527475,0.22459171823527493,0.22018340904306277,0.23661621492182247,0.29391308314659803,0.29449369690092986,0.2677964961255061,0.38104672448013294,0.3174521290766084,21.659826721386228,19.37984496124031,18.23985408116735,22.11582307341541,27.218664226898447,27.218664226898447,22.872827081427268,29.18376652986776,27.587779297765618
B2CL1_HUMAN_3IO8_A,B2CL1,3IO8,A,2.3,10.1074/JBC.M109.040725,19726685,CONFORMATIONAL CHANGES IN BCL-2 PRO-SURVIVAL PROTEINSDETERMINE THEIR CAPACITY TO BIND LIGANDS.,"E.F.LEE,P.E.CZABOTAR,H.YANG,B.E.SLEEBS,G.LESSENE,P.M.COLMAN,B.J.SMITH,W.D.FAIRLIE",0.7494743702716153,0.6875082753866033,0.6788870346949862,0.596580610255544,0.7776934322986955,0.7776934322986955,0.6377206753146603,0.8174712244832735,0.821914821731051,0.3405849952665625,0.2885324706441369,0.28270784823137535,0.17078828776281785,0.3423604124213252,0.3423604124213252,0.18914293005318952,0.4236679100611437,0.4486293141804162,26.447788417692657,27.131782945736433,26.903784769721838,16.643866849065205,27.441115938714837,27.441115938714837,18.980105190944432,33.7437300501596,38.75968992248062
B2CL1_HUMAN_3PL7_A,B2CL1,3PL7,A,2.61,10.1074/JBC.M110.161281,21199865,MUTATION TO BAX BEYOND THE BH3 DOMAIN DISRUPTS INTERACTIONSWITH PRO-SURVIVAL PROTEINS AND PROMOTES APOPTOSIS,"P.E.CZABOTAR,E.F.LEE,G.V.THOMPSON,A.Z.WARDAK,W.D.FAIRLIE,P.M.COLMAN",0.6450441277856663,0.6455674746487812,0.6364400085835734,0.5262141418937738,0.7145882668181256,0.7145882668181256,0.5230297360308903,0.7650897394337581,0.8062897503915114,0.22831135351347076,0.22015478574795572,0.21151824630108876,0.1097186269797886,0.2537877437403211,0.2537877437403211,0.07391718765147264,0.36568789546952757,0.410206259296869,16.643866849065205,23.02781577747378,21.88782489740082,13.223894208846328,20.109689213893965,20.109689213893965,12.340036563071298,32.375740994072046,32.60373917008664
B2CL1_HUMAN_4CIN_A,B2CL1,4CIN,A,2.69,10.1074/JBC.M114.610758,25371206,THE FUNCTIONAL DIFFERENCES OF PRO-SURVIVAL ANDPRO-APOPTOTIC B CELL LYMPHOMA 2 (BCL-2) PROTEINS DEPEND ONSTRUCTURAL DIFFERENCES IN THEIR BCL-2 HOMOLOGY 3 (BH3)DOMAINS,"E.F.LEE,G.DEWSON,M.EVANGELISTA,A.PETTIKIRIARACHCHI,H.ZHU,P.M.COLMAN,W.D.FAIRLIE",0.5218264748451076,0.6279905535035133,0.6353858955452166,0.6235047232482434,0.7268630511119781,0.7268630511119781,0.5425093525510087,0.6985031252425544,0.6165425548914953,0.0798477557361553,0.18961846099754798,0.1984630781277064,0.17709805100666387,0.24066523467140605,0.24066523467140605,0.07331752812966125,0.2756237146769927,0.20350743889562786,13.223894208846328,20.74783401732786,21.88782489740082,18.23985408116735,21.252285191956126,21.252285191956126,14.853747714808044,23.48381212950296,17.327861377108984
B2CL1_HUMAN_4HNJ_A,B2CL1,4HNJ,A,2.9,10.1038/NCHEMBIO.1166,23340338,PUMA BINDING INDUCES PARTIAL UNFOLDING WITHIN BCL-XL TODISRUPT P53 BINDING AND PROMOTE APOPTOSIS.,"A.V.FOLLIS,J.E.CHIPUK,J.C.FISHER,M.K.YUN,C.R.GRACE,A.NOURSE,K.BARAN,L.OU,L.MIN,S.W.WHITE,D.R.GREEN,R.W.KRIWACKI",0.8164416522465677,0.7459604699049871,0.7417702707021638,0.7265909288065637,0.7888503821349062,0.7888515296871774,0.6465561956347112,0.8018621332006228,0.8514436839966579,0.30274561500247754,0.3361220238756205,0.3333237150463064,0.2912007169084454,0.35060909197548706,0.3506159294384879,0.21678739105998449,0.38061971774957304,0.4507848058733179,21.88782489740082,25.763793889648884,25.99179206566347,22.79981760145919,25.822669104204753,25.822669104204753,19.652650822669106,31.007751937984494,33.515731874145004
B2CL1_HUMAN_4QVE_A,B2CL1,4QVE,A,2.05,10.1002/PROT.24816,25907960,BH3 INDUCED CONFORMATIONAL CHANGES IN BCL-XL REVEALED BYCRYSTAL STRUCTURE AND COMPARATIVE ANALYSIS,"S.RAJAN,M.CHOI,K.BAEK,H.S.YOON",0.7927483643270342,0.6180406852248395,0.6108216945252326,0.5764708500933692,0.6323091857366051,0.6323091857366051,0.5381783613638453,0.8002801075686116,0.7646822479830886,0.36989118388698017,0.19467592907329942,0.18669086606142596,0.1320754797080975,0.1789536026246561,0.1789536026246561,0.06046243180286552,0.393114703008314,0.352210692084674,27.131782945736433,15.959872321021432,15.731874145006838,15.275877792977655,17.38334858188472,17.38334858188472,13.72369624885636,31.69174646602827,32.14774281805746
B2CL1_HUMAN_4QVF_A,B2CL1,4QVF,A,1.53,10.1002/PROT.24816,25907960,BH3 INDUCED CONFORMATIONAL CHANGES IN BCL-XL REVEALED BYCRYSTAL STRUCTURE AND COMPARATIVE ANALYSIS,"S.RAJAN,M.CHOI,K.BAEK,H.S.YOON",0.6732494989110733,0.5477466978353871,0.5413523922145163,0.514417435611785,0.646421872530855,0.646421872530855,0.5646895948369247,0.7261600379868781,0.655254242705104,0.2435759596920328,0.1344101934244421,0.1300943643871815,0.09748892000862151,0.216915402714746,0.216915402714746,0.11844419431277141,0.31890991418957604,0.2539681512027691,25.3077975376197,16.415868673050614,15.503875968992247,13.907888736890103,19.415258108725446,19.415258108725446,17.355560630280888,36.4797081623347,35.11171910624714
B2CL1_HUMAN_5FMK_A,B2CL1,5FMK,A,1.73,10.1101/GAD.279414.116,27198225,PHYSIOLOGICAL RESTRAINT OF BAK BY BCL-XL IS ESSENTIAL FORCELL SURVIVAL.,"E.F.LEE,S.GRABOW,S.CHAPPAZ,G.DEWSON,C.HOCKINGS,R.M.KLUCK,D.H.GRAY,M.T.WITKOWSKI,M.EVANGELISTA,A.PETTIKIRIARACHCHI,P.BOUILLET,R.M.LANE,P.E.CZABOTAR,P.M.COLMAN,B.J.SMITH,B.T.KILE,W.D.FAIRLIE",0.6267384019029965,0.66721360313757,0.6664882226980728,0.6345349575158774,0.6621334879853036,0.6621334879853036,0.6442421309943366,0.7300637375983345,0.6835948735977501,0.1590533501880897,0.254483618104653,0.24997737607385592,0.21352325671350483,0.22289584408635352,0.22289584408635352,0.19267884913745006,0.3134468527686057,0.28295296386542573,15.275877792977655,18.23985408116735,18.011855905152757,16.8718650250798,19.173704633645286,19.173704633645286,15.978087194704404,25.3077975376197,23.939808481532147
B2CL1_HUMAN_MIN,B2CL1,HUMAN,MIN,,,,,,0.801427247366715,0.6444169105527731,0.6468019340434566,0.5614176365039287,0.7042399656657065,0.7042399656657065,0.5845927140072047,0.7839736009460194,0.7744049711674117,0.38996079556195123,0.23246775180140242,0.23051465832078954,0.14808071879328927,0.250287061206287,0.2502911579561749,0.16098849378822733,0.3914783150275088,0.38442824958619193,27.359781121751027,19.37984496124031,18.923848609211124,15.731874145006838,20.063839489284085,20.063839489284085,16.415868673050614,36.70770633834929,35.56771545827633
B2LA1_HUMAN_2VM6_A,B2LA1,2VM6,A,2.2,10.1016/J.FEBSLET.2008.09.028,18812174,COMPLETING THE FAMILY PORTRAIT OF THE ANTI- APOPTOTIC BCL-2PROTEINS: CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITHBIM.,"M.D.HERMAN,T.NYMAN,M.WELIN,L.LEHTIO,S.FLODIN,L.TRESAUGUES,T.KOTENYOVA,A.FLORES,P.NORDLUND",0.8403030187898668,0.7027892813470504,0.7013715631767583,0.6882068362862679,0.7218129560841214,0.7218129560841214,0.6702612260382368,0.7359146357765929,0.7413913197654539,0.4595839135994562,0.29115423371872545,0.28465869449823783,0.24853431254734026,0.31246718244395905,0.31246718244395905,0.23333248354580263,0.3003179604302643,0.3210941213916007,27.8580814717477,18.134034165571617,19.71090670170828,25.229960578186596,17.41424802110818,17.41424802110818,19.519915589554206,33.11432325886991,30.223390275952696
B2LA1_HUMAN_3MQP_A,B2LA1,3MQP,A,2.24,,,CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITH NOXA BH3PEPTIDE,"R.GUAN,R.XIAO,L.ZHAO,T.B.ACTON,C.GELINAS,G.T.MONTELIONE",0.7757331678507956,0.6998532327492195,0.7011154592492215,0.6685262344701814,0.6825057542204694,0.6825057542204694,0.6452618630368128,0.7485706727231025,0.783578109587152,0.33851205033367376,0.27299767938726877,0.2750555363418182,0.2209334032580732,0.26714818337971025,0.26714818337971025,0.208469235626136,0.3014224522862961,0.37931148335496695,14.98028909329829,12.87779237844941,14.71747700394218,19.44809461235217,13.965744400527008,13.965744400527008,18.181818181818183,31.537450722733247,28.12089356110381
B2LA1_HUMAN_4ZEQ_A,B2LA1,4ZEQ,A,1.8,,,CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITH TBID BH3PEPTIDE,"R.GUAN,R.XIAO,L.MAO,C.GELINAS,G.T.MONTELIONE",0.77261066996506,0.732704190113544,0.7329694406099214,0.6852623447018148,0.7314639442608935,0.7314639442608935,0.6676200466002487,0.6881611034420649,0.723223419719158,0.3240556414264968,0.3206060516143031,0.3178626628246925,0.26171177146447816,0.34319904733141066,0.34319904733141066,0.2281574192943432,0.2686345720197818,0.3193156845361467,17.871222076215506,18.659658344283837,20.2365308804205,23.390275952693823,23.99789029535865,23.99789029535865,16.877637130801688,29.172141918528254,25.75558475689882
B2LA1_HUMAN_5UUK_A,B2LA1,5UUK,A,1.2,10.7554/ELIFE.25541,28594323,EPISTATIC MUTATIONS IN PUMA BH3 DRIVE AN ALTERNATE BINDINGMODE TO POTENTLY AND SELECTIVELY INHIBIT ANTI-APOPTOTICBFL-1.,"J.M.JENSON,J.A.RYAN,R.A.GRANT,A.LETAI,A.E.KEATING",0.6745685985627222,0.6681821827653315,0.661783806070226,0.5769796341091031,0.7383086183403927,0.7383086183403927,0.6059542130220941,0.6897216488027141,0.7519281670698192,0.25207090237919344,0.23532997665770283,0.2280453653736916,0.10351486351260367,0.31527461091002057,0.31527461091002057,0.15529053999546316,0.266624653761185,0.3430123767828276,18.134034165571617,19.97371879106439,19.44809461235217,19.97371879106439,23.243528790279978,23.243528790279978,18.4891706286318,28.383705650459923,27.06964520367937
B2LA1_HUMAN_5UUL_A,B2LA1,5UUL,A,1.33,10.7554/ELIFE.25541,28594323,EPISTATIC MUTATIONS IN PUMA BH3 DRIVE AN ALTERNATE BINDINGMODE TO POTENTLY AND SELECTIVELY INHIBIT ANTI-APOPTOTICBFL-1.,"J.M.JENSON,J.A.RYAN,R.A.GRANT,A.LETAI,A.E.KEATING",0.6932641852728985,0.7025838353392462,0.7009958502720752,0.6938326797054524,0.7100359704034496,0.7100359704034496,0.6558639162456354,0.5801879690254964,0.6780506269621149,0.2736928988039883,0.31067338418861506,0.30669927055527424,0.2701214118975347,0.31438242419866935,0.31438242419866935,0.22203416034579224,0.11035462662037655,0.23624134923821835,19.71090670170828,17.345597897503286,18.396846254927727,25.229960578186596,19.027484143763214,19.027484143763214,19.820295983086684,23.127463863337713,27.8580814717477
B2LA1_HUMAN_5UUP_A,B2LA1,5UUP,A,1.73,10.7554/ELIFE.25541,28594323,EPISTATIC MUTATIONS IN PUMA BH3 DRIVE AN ALTERNATE BINDINGMODE TO POTENTLY AND SELECTIVELY INHIBIT ANTI-APOPTOTICBFL-1.,"J.M.JENSON,J.A.RYAN,R.A.GRANT,A.LETAI,A.E.KEATING",0.7387092643485039,0.7183152301628511,0.7216276952475836,0.6481863761153537,0.7423265427889532,0.7424117797476986,0.6311185930219342,0.6531860313600666,0.7113582091862509,0.38167566576640205,0.2958500269544359,0.2963077678678665,0.1802174760018296,0.3412332176587458,0.3416672582739123,0.1803527333750664,0.2083403197365881,0.29846680286182214,21.02496714848883,16.819973718791065,19.185282522996058,19.97371879106439,16.120507399577168,16.384778012684993,17.706131078224104,20.76215505913272,26.28120893561104
B2LA1_HUMAN_MIN,B2LA1,HUMAN,MIN,,,,,,0.8342071824487194,0.7105125033596051,0.7084369358150087,0.6887711092255108,0.7266357934789185,0.7266357934789185,0.6526196476741684,0.6969769886399615,0.7490364441517543,0.46329287468929126,0.2914687343401633,0.28704751382930804,0.26275141343643943,0.32957278265065115,0.32957278265065115,0.22017025274039068,0.256361138272769,0.33160140066039656,27.33245729303548,17.082785808147175,19.71090670170828,25.75558475689882,19.97371879106439,19.97371879106439,18.922470433639948,30.486202365308806,29.172141918528254
MCL1_HUMAN_2KBW_A,MCL1,2KBW,A,-999.0,10.1074/JBC.M110.105452,20392693,APOPTOTIC REGULATION BY MCL-1 THROUGH HETERODIMERIZATION.,"Q.LIU,T.MOLDOVEANU,T.SPRULES,E.MATTA-CAMACHO,N.MANSUR-AZZAM,K.GEHRING",0.7950357578929008,0.7612710041281471,0.7731751846037561,0.6843915343915343,0.7923510135891119,0.7923510135891119,0.6980157014636501,0.7621012849584278,0.8419489505203791,0.31160953492445204,0.31505562893201183,0.331255906913183,0.24133522516435355,0.3910006891171745,0.3910006891171745,0.2795835772988733,0.3082642122985229,0.37534255171487246,18.036072144288575,23.38009352037408,24.270763749721663,20.040080160320638,32.33719892952721,32.33719892952721,24.754683318465656,30.282787797817857,23.38009352037408
MCL1_HUMAN_2NL9_A,MCL1,2NL9,A,1.55,10.1073/PNAS.0701297104,17389404,STRUCTURAL INSIGHTS INTO THE DEGRADATION OF MCL-1 INDUCED BYBH3 DOMAINS.,"P.E.CZABOTAR,E.F.LEE,M.F.VAN DELFT,C.L.DAY,B.J.SMITH,D.C.HUANG,W.D.FAIRLIE,M.G.HINDS,P.M.COLMAN",0.8965023486475631,0.8561946670857561,0.856864628261768,0.77128247216256,0.854496618289418,0.854496618289418,0.776912192945376,0.8970358741787314,0.9097447526018956,0.4123726862933506,0.4425608643611342,0.4461345380407478,0.36338960994307173,0.44613406908201897,0.44613406908201897,0.3756705451854864,0.5486295564267375,0.5487437531726846,30.282787797817857,27.388109552438205,27.388109552438205,27.833444667112,30.648769574944073,30.648769574944073,29.30648769574944,48.98686261411712,49.43219772879091
MCL1_HUMAN_2PQK_A,MCL1,2PQK,A,2.0,10.1002/PRO.329,20066663,MCL-1-BIM COMPLEXES ACCOMMODATE SURPRISING POINT MUTATIONSVIA MINOR STRUCTURAL CHANGES.,"E.FIRE,S.V.GULLA,R.A.GRANT,A.E.KEATING",0.8999324800204889,0.8610043014883498,0.8623686707295068,0.7851066058986852,0.8686674672678198,0.8686674672678198,0.7543564875614204,0.8980347694633408,0.9102540845397988,0.4912780450568978,0.47527879212681284,0.4808861062075108,0.3762348310233684,0.46228996915434,0.46228996915434,0.3627005179187517,0.5653721442266639,0.5726726514889876,24.49343130705856,31.17345802716544,32.28679581384992,32.50946337118681,33.035714285714285,33.035714285714285,29.6875,48.318859942106435,46.982854598085055
MCL1_HUMAN_3D7V_A,MCL1,3D7V,A,2.03,10.1083/JCB.200708096,18209102,A NOVEL BH3 LIGAND THAT SELECTIVELY TARGETS MCL-1 REVEALSTHAT APOPTOSIS CAN PROCEED WITHOUT MCL-1 DEGRADATION.,"E.F.LEE,P.E.CZABOTAR,M.F.VAN DELFT,E.M.MICHALAK,M.J.BOYLE,S.N.WILLIS,H.PUTHALAKATH,P.BOUILLET,P.M.COLMAN,D.C.S.HUANG,W.D.FAIRLIE",0.9264689807546951,0.8803593232164661,0.883788010930868,0.8222158265015408,0.9035864268544759,0.9035864268544759,0.8028751274353003,0.8719506948078378,0.8973324030466886,0.5176542675341615,0.5006309883098735,0.5080486687856492,0.44561784173925456,0.5404226612894144,0.5404226612894144,0.39467308213411995,0.4990849156079111,0.5322034457992261,37.85348474727232,37.63081718993542,38.298819861946114,37.63081718993542,40.85733422638982,40.85733422638982,27.68475106050458,46.31485192607437,45.64684925406368
MCL1_HUMAN_3IO9_A,MCL1,3IO9,A,2.4,10.1074/JBC.M109.040725,19726685,CONFORMATIONAL CHANGES IN BCL-2 PRO-SURVIVAL PROTEINSDETERMINE THEIR CAPACITY TO BIND LIGANDS.,"E.F.LEE,P.E.CZABOTAR,H.YANG,B.E.SLEEBS,G.LESSENE,P.M.COLMAN,B.J.SMITH,W.D.FAIRLIE",0.9189092389092389,0.8594772951915808,0.8632664689807548,0.8231379731379732,0.790129490656072,0.790129490656072,0.7222222222222222,0.900772137914995,0.921683818826676,0.5383136193771368,0.4788338611317633,0.48703898582645316,0.45518705191528697,0.3829225078632367,0.3829225078632367,0.33267466773479654,0.5399919428194131,0.5685014105153922,36.517479403250945,36.07214428857715,37.40814963259853,36.740146960587836,30.587184639428443,30.587184639428443,32.81982585398527,46.31485192607437,47.87352482743264
MCL1_HUMAN_3KJ0_A,MCL1,3KJ0,A,1.7,10.1002/PRO.329,20066663,MCL-1-BIM COMPLEXES ACCOMMODATE SURPRISING POINT MUTATIONSVIA MINOR STRUCTURAL CHANGES.,"E.FIRE,S.V.GULLA,R.A.GRANT,A.E.KEATING",0.8831577417291703,0.8671120413977557,0.8729280772137915,0.783085063085063,0.8432918536412943,0.8432918536412943,0.7819038991378685,0.788193499622071,0.8073539159253446,0.4882580725277499,0.44385582620584774,0.4564968149761244,0.37469084823755217,0.4496955162655206,0.4496955162655206,0.3940097770945033,0.41265613269339074,0.4346447842306945,29.61478512580717,27.833444667112,29.169450011133375,26.942774437764417,33.51206434316354,33.51206434316354,29.93744414655943,35.84947673124025,36.962814517924734
MCL1_HUMAN_3KJ1_A,MCL1,3KJ1,A,1.95,10.1002/PRO.329,20066663,MCL-1-BIM COMPLEXES ACCOMMODATE SURPRISING POINT MUTATIONSVIA MINOR STRUCTURAL CHANGES.,"E.FIRE,S.V.GULLA,R.A.GRANT,A.E.KEATING",0.8484440955869528,0.8857799872085586,0.8884074655503226,0.7888214431071574,0.8852575768180864,0.8852575768180864,0.8118441006976038,0.9030455259026687,0.9120774463631606,0.3919961974429157,0.48572945511550103,0.49465304471454247,0.41663061455028366,0.4878700991497333,0.4878700991497333,0.4249085110355934,0.546356581275015,0.5389342000347923,26.052104208416832,35.40414161656646,35.84947673124025,35.84947673124025,36.160714285714285,36.160714285714285,32.8125,42.97483856602093,41.861500779336446
MCL1_HUMAN_3KJ2_A,MCL1,3KJ2,A,2.35,10.1002/PRO.329,20066663,MCL-1-BIM COMPLEXES ACCOMMODATE SURPRISING POINT MUTATIONSVIA MINOR STRUCTURAL CHANGES.,"E.FIRE,S.V.GULLA,R.A.GRANT,A.E.KEATING",0.910437234722949,0.8816280016280016,0.8849002849002849,0.8350909936624221,0.8803460458438606,0.8803460458438606,0.8074549643069113,0.9121634978777836,0.9187278330135473,0.45450772105526893,0.4851153339060782,0.49552222344519137,0.45306675525907275,0.49195051805796064,0.49195051805796064,0.4249699716934896,0.574528494231383,0.5820011216891066,27.833444667112,36.517479403250945,38.07615230460922,32.95479848586061,38.702460850111855,38.702460850111855,35.79418344519016,42.97483856602093,43.86550879536851
MCL1_HUMAN_3KZ0_A,MCL1,3KZ0,A,2.35,10.1016/J.JMB.2010.03.058,20363230,DETERMINANTS OF BH3 BINDING SPECIFICITY FOR MCL-1 VERSUSBCL-XL.,"S.DUTTA,S.GULLA,T.S.CHEN,E.FIRE,R.A.GRANT,A.E.KEATING",0.9186627129484272,0.8690266875981161,0.8730647130647131,0.8189150532007675,0.8904845581151735,0.8904845581151735,0.8209528185414854,0.8897494040351183,0.9281632653061225,0.5539456736608782,0.4793984556220685,0.48954827532820644,0.46367431427688083,0.5189158508815174,0.5189158508815174,0.46406513928105353,0.49628770065064526,0.5562725655067515,42.08416833667334,38.298819861946114,39.857492763304386,36.517479403250945,41.54567790931427,41.54567790931427,39.75876703149431,42.08416833667334,45.201514139389886
MCL1_HUMAN_3KZ0_B,MCL1,3KZ0,B,2.35,10.1016/J.JMB.2010.03.058,20363230,DETERMINANTS OF BH3 BINDING SPECIFICITY FOR MCL-1 VERSUSBCL-XL.,"S.DUTTA,S.GULLA,T.S.CHEN,E.FIRE,R.A.GRANT,A.E.KEATING",0.9235566021280308,0.873105413105413,0.8771975114832258,0.8163143206000347,0.8729558856783993,0.8729558856783993,0.8035787305489128,0.8795883481597768,0.9039455782312926,0.5347684951259472,0.48134863597834676,0.49110688566481703,0.4674821315683683,0.492474267729552,0.492474267729552,0.41518178122326543,0.47907282767305576,0.5176371477631015,33.622801157871294,38.521487419283005,39.857492763304386,40.080160320641276,37.533512064343164,37.533512064343164,35.299374441465595,34.95880650189267,36.29481184591405
MCL1_HUMAN_3PK1_A,MCL1,3PK1,A,2.49,10.1074/JBC.M110.161281,21199865,MUTATION TO BAX BEYOND THE BH3 DOMAIN DISRUPTS INTERACTIONSWITH PRO-SURVIVAL PROTEINS AND PROMOTES APOPTOSIS,"P.E.CZABOTAR,E.F.LEE,G.V.THOMPSON,A.Z.WARDAK,W.D.FAIRLIE,P.M.COLMAN",0.8344525844525844,0.8481464038606895,0.8524350252921682,0.8024385138670853,0.8596083308444711,0.8596083308444711,0.7827975668259539,0.7817291703005989,0.8260968660968662,0.34550782570314986,0.4463332059744034,0.4538045482138501,0.4139453417436201,0.4784919144415129,0.4784919144415129,0.4043382888153115,0.3781857890978812,0.4513835763745293,9.797372522823423,34.95880650189267,37.18548207526163,30.950790469828544,35.921463632307,35.921463632307,33.020972780008925,32.28679581384992,38.521487419283005
MCL1_HUMAN_3PK1_C,MCL1,3PK1,C,2.49,10.1074/JBC.M110.161281,21199865,MUTATION TO BAX BEYOND THE BH3 DOMAIN DISRUPTS INTERACTIONSWITH PRO-SURVIVAL PROTEINS AND PROMOTES APOPTOSIS,"P.E.CZABOTAR,E.F.LEE,G.V.THOMPSON,A.Z.WARDAK,W.D.FAIRLIE,P.M.COLMAN",0.868672015814873,0.8588272573986859,0.8629844758416187,0.8018972033257749,0.8644120100569934,0.8644120100569934,0.8104816739877381,0.7672004186289901,0.8044735159020873,0.3865271408998846,0.4484017449754156,0.45695965039463005,0.40012584580270816,0.47840287541420423,0.47840287541420423,0.4329656805055164,0.385438013379784,0.4403086673010779,7.570696949454464,28.501447339122688,31.17345802716544,29.169450011133375,38.35860838537021,38.35860838537021,38.804638715432645,34.06813627254509,38.9668225339568
MCL1_HUMAN_5C6H_A,MCL1,5C6H,A,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.8335391592534449,0.8226972498401071,0.825791034362463,0.7647514390371534,0.8129183365126034,0.8129183365126034,0.8091288800219341,0.8594767137624281,0.8097052154195011,0.40619877568042945,0.4138152012838397,0.4220071530656288,0.228470512919341,0.42347618990636243,0.42347618990636243,0.31490020262751417,0.4798209887961004,0.4036708029562324,25.384101536406146,30.06012024048096,30.950790469828544,34.06813627254509,35.24425607851885,35.24425607851885,33.23667187151461,39.18949009129369,29.61478512580717
MCL1_HUMAN_5C6H_C,MCL1,5C6H,C,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.8436804465375893,0.8417442874585732,0.8519175533461248,0.7184092098377812,0.8581828247341767,0.8581536262216657,0.7554431867022966,0.739938368509797,0.8196325367753939,0.4160528698816673,0.43835645871474727,0.45462394313294324,0.3253328221885149,0.4819104648956929,0.4818497475372907,0.3672954112973943,0.3173449762521745,0.4281584193827214,27.610777109775103,28.724114896459586,29.61478512580717,28.27877978178579,38.435754189944134,38.435754189944134,31.05451295799821,31.61879314183923,38.298819861946114
MCL1_HUMAN_5C6H_E,MCL1,5C6H,E,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.7451136693993836,0.7877876620733764,0.7914971800686088,0.6676934705506135,0.7879183500540713,0.7879183500540713,0.7663542159198903,0.6247119018547589,0.646420140705855,0.2565336428112249,0.33600989903363626,0.3439866143482635,0.24707707691214545,0.35749437170971216,0.35749436921303024,0.36173985737598,0.12175285876500455,0.16920623423065087,20.48541527499443,18.704074816299265,18.92674237363616,21.376085504342015,22.539611693818344,22.539611693818344,31.019861638027223,19.149409930973057,16.922734357604096
MCL1_HUMAN_5C6H_G,MCL1,5C6H,G,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.7290999476713763,0.847482411768126,0.8515843944415372,0.7680894238037095,0.8485309296488306,0.8485039527082503,0.7934369795209835,0.7326484097912669,0.8006477120762836,0.2244104070380581,0.46427186910967266,0.47308157445224575,0.38465626959895405,0.4620881628167302,0.4620092562609468,0.399292402217106,0.30487089771669673,0.40647568310050325,15.58672901358272,30.72812291249165,32.06412825651302,34.06813627254509,36.664431030628215,36.440867426782916,33.3109769729488,31.39612558450234,35.84947673124025
MCL1_HUMAN_5C6H_I,MCL1,5C6H,I,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.8356613756613757,0.8484743299029014,0.8573265887551601,0.730534914820629,0.7806863755158584,0.7806863755158584,0.6862730717516194,0.7416663759520903,0.7442618756904471,0.38058504124217823,0.4172383856496133,0.4349402488891255,0.31027858949601006,0.35426414852242044,0.35426414852242044,0.24416389425316717,0.2952207814120972,0.32465900016024346,22.044088176352705,26.497439323090628,29.169450011133375,27.388109552438205,27.039106145251395,27.039106145251395,19.217877094972067,28.501447339122688,24.716098864395455
MCL1_HUMAN_5C6H_K,MCL1,5C6H,K,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.7699587185301471,0.8629298215012501,0.8681388452817024,0.7991790220361648,0.8588612024917757,0.8588612024917757,0.7834074099997667,0.7838130123844409,0.8193243793243793,0.2702053990822602,0.45912353130029104,0.47240985547880643,0.41673674376028985,0.4536430876044918,0.45364345823667207,0.405088647912438,0.34508392365166485,0.39903755627063153,12.469383210866177,30.06012024048096,30.72812291249165,33.400133600534396,31.480241125251172,31.480241125251172,33.48961821835231,27.388109552438205,29.61478512580717
MCL1_HUMAN_5C6H_M,MCL1,5C6H,M,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.821127972556544,0.8258456887028317,0.8287382987382987,0.7336827722542009,0.8555736518488811,0.8555736518488811,0.7312653673969748,0.765014245014245,0.7956602128030699,0.3592157649452919,0.42483011584641495,0.43187643856486885,0.3390636984365821,0.4860962588534974,0.4860962588534974,0.33396334875980843,0.348233107119081,0.3921400483429977,19.37207748830995,28.501447339122688,28.501447339122688,24.716098864395455,37.79915007828226,37.79915007828226,26.839633191679713,33.622801157871294,32.95479848586061
MCL1_HUMAN_5C6H_O,MCL1,5C6H,O,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.7887359730216873,0.8100040700040699,0.8158218501075644,0.7396121867550439,0.8294800317783633,0.8294741987454312,0.7829814264565376,0.7876527705099133,0.7893551950694808,0.319889626348857,0.38873252205984565,0.39901242720884744,0.3251923946647933,0.45169021341342547,0.45166111940659365,0.4006378903819436,0.3864365775903924,0.398398999807725,20.48541527499443,24.716098864395455,26.27477176575373,24.938766421732353,34.14416424905155,34.14416424905155,32.35884847132336,34.95880650189267,35.62680917390336
MCL1_HUMAN_5C6H_Q,MCL1,5C6H,Q,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.7900348857491715,0.8437914995057852,0.851818710390139,0.7663399034827607,0.8315443365422804,0.8315443365422804,0.74681067680783,0.7938019652305366,0.8154067096924239,0.33712057030228915,0.4341862791205965,0.4502248548219638,0.3803736505687581,0.46160319039795256,0.46160319039795256,0.3739536090671445,0.3585800973694887,0.4020227783641704,24.49343130705856,25.829436651079934,27.388109552438205,30.950790469828544,33.29608938547486,33.29608938547486,31.955307262569832,28.946782453796484,28.27877978178579
MCL1_HUMAN_5C6H_U,MCL1,5C6H,U,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.7486836443979302,0.8540043025757312,0.8608645851502994,0.7894586894586895,0.8404939645608249,0.8404939645608249,0.7749055923619933,0.7547136461422176,0.7941857084714228,0.2890325458046407,0.44008314797307635,0.45494136460994566,0.40696900999884494,0.43432514376096326,0.43432514376096326,0.38379911597046384,0.26086007543249246,0.3234842105225831,24.270763749721663,31.17345802716544,32.73213092852371,33.622801157871294,32.59656173252958,32.59656173252958,31.256977003795495,22.2667557336896,18.481407258962367
MCL1_HUMAN_5C6H_W,MCL1,5C6H,W,2.05,,,STRUCTURE OF MCL-1 COMPLEXED WITH MULE AT 2.05 ANGSTROMSRESOLUTION,"T.SONG,Z.WANG,F.JI,G.CHAI,Y.LIU,X.LI,Z.LI,Y.FAN,Z.ZHANG",0.71420954706669,0.8300907029478459,0.8358799930228501,0.7545642188499332,0.8491335318441514,0.8491335318441514,0.7406587098667358,0.7471422757137043,0.8028199313913599,0.22805913098886504,0.4087480035111226,0.4214451597431402,0.35794542802698,0.4605157167346945,0.4605157167346945,0.35219853319418876,0.32589744143327626,0.4109224812905674,19.817412602983744,27.388109552438205,28.501447339122688,28.0561122244489,30.16759776536313,30.16759776536313,29.720670391061454,32.50946337118681,37.63081718993542
MCL1_HUMAN_5UUM_A,MCL1,5UUM,A,2.35,10.7554/ELIFE.25541,28594323,EPISTATIC MUTATIONS IN PUMA BH3 DRIVE AN ALTERNATE BINDINGMODE TO POTENTLY AND SELECTIVELY INHIBIT ANTI-APOPTOTICBFL-1.,"J.M.JENSON,J.A.RYAN,R.A.GRANT,A.LETAI,A.E.KEATING",0.6561730333158906,0.8678434792720507,0.8700308157451015,0.7683376940519797,0.8597543115568469,0.8597543115568469,0.7980082481957071,0.755120646549218,0.8356892842607128,0.19127937336290726,0.46176179501217895,0.4688296275249696,0.3714015743856104,0.45940698163121846,0.45940698163121846,0.4293792924021114,0.32980296361255007,0.41775551226735386,23.38009352037408,29.61478512580717,30.282787797817857,30.950790469828544,33.29608938547486,33.29608938547486,35.3072625698324,30.505455355154755,31.61879314183923
MCL1_HUMAN_5UUM_B,MCL1,5UUM,B,2.35,10.7554/ELIFE.25541,28594323,EPISTATIC MUTATIONS IN PUMA BH3 DRIVE AN ALTERNATE BINDINGMODE TO POTENTLY AND SELECTIVELY INHIBIT ANTI-APOPTOTICBFL-1.,"J.M.JENSON,J.A.RYAN,R.A.GRANT,A.LETAI,A.E.KEATING",0.6553898482469911,0.877527181812896,0.8799872085586371,0.7885882900168615,0.8614199566018501,0.8614199566018501,0.7795684970584658,0.6713099598813884,0.7338833653119368,0.17376675840562478,0.47069021997644384,0.47762887099724505,0.3908078536981534,0.44622322585848057,0.44622322585848057,0.3739136892704965,0.23841370682072477,0.31286673381752017,18.258739701625473,28.724114896459586,29.169450011133375,32.73213092852371,28.15013404825737,28.15013404825737,30.38427167113494,24.49343130705856,27.165441995101315
MCL1_HUMAN_MIN,MCL1,HUMAN,MIN,,,,,,0.9313250770393627,0.8988499331356474,0.8999209256352113,0.8039327867899295,0.9193104250247108,0.9192813535670679,0.8351851851851851,0.8675527646956218,0.8904692133263563,0.5608239598928684,0.5151219467540653,0.5218369863388719,0.4064083430369954,0.5396631327172974,0.5396404231590085,0.46136217318469974,0.48923414424170153,0.5092513096323191,32.73213092852371,34.06813627254509,34.95880650189267,26.942774437764417,38.298819861946114,38.298819861946114,35.181474059229565,45.201514139389886,42.30683589401024
